JW Pharma Faces Business Suspension for Sales Regulation Violation (Fine of 285.3 Million Won)
-
Reason for business suspension: violation of pharmaceutical sales order regulations
-
Fine of 285,300,000 won imposed in lieu of 3-month sales suspension for Encover Liquid
-
Sales suspension period: until August 5, 2026
-
Board resolution date: based on receipt of administrative disposition notice
KOSPI Filing Information
-
Filing: Report on Major Facts (Suspension of Business)
-
Company: JW Pharmaceutical (001060)
-
Submission: JW Pharmaceutical
-
Receipt: 04-30-2026